Eastman Chemical Company (EMN) has shown declining revenue growth over the past 3 years, expanding from $10.6B to $8.8B (average -5.9%/yr). Net income reached $474M, reflecting earnings decline at -11.2%/yr on average. The net profit margin is 5.4%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 21.1% (low), with a +0.9pp trend over the period. With a $8B market cap and MOAT composite score of 49/100, the company has a moderate competitive position.
Criteria proven by this page:
Overall SharesGrow Score: 52/100 with 2/7 criteria passed.